Nucleix
Rehovot, Israel · $60.0M raised
- Headquarters
- Rehovot
- Employees
- 51–200
- Website
- nucleix.com
- Total Funding
- $60.0M
- Last Round
- $55.0M Venture RoundApr 2021
- Rounds
- 2
About
Developer of non-invasive molecular diagnostic tests for accurate and early cancer detection, with FDA-cleared Bladder EpiCheck for bladder cancer monitoring.
Summary
Nucleix is a Biotech company based in Rehovot, Israel. It has raised $60.0M in total across 2 rounds, most recently a $55.0M Venture Round round in Apr 2021. Investors include RA Capital Management, OrbiMed and BlackRock.
Tech & App Stack
5 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Apr 2021
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company